About us
What we do
Downloads
Press
Pricing
LOGIN
Home
Advanced Search
Taxonomy
Analysis
Analyst Insights
Market Sizing
Data
Vendors
Buyers
Products
Deployments
Home
Advanced Search
Taxonomy
Analysis
Analyst Insights
Market Sizing
Data
Vendors
Buyers
Products
Deployments
diagonalfilm
Inactive
http://diagonal.com
https://www.linkedin.com/company/diagonalfilm/
Summary
Product Portfolio
Revenue Breakdown
Featured News
Relationships
Revenue
Subscribe
Founded
2004
Headcount
2
Headquarters
Switzerland
Primary Segment
-
Ownership
Privately Owned
Subscribe
for full access to diagonalfilm's products in full detail
Subscribe
for full access to diagonalfilm's revenue in full detail
Jan
8th
2026
18:30
Funding Activities, Capital Investment, B2B Tag
Financings for Jan. 9, 2026
Biopharmas raising money in public or private financings, including: 32 Biosciences, Aktis, Alumis, Alveus, Arrowhead, Beacon, Bright Minds, Century, Diagonal, Engitix, Enodia, Epibiologics, Genelux, Invea, Parabilis, Phathom, Spruce.
BioWorld
Nov
25th
2025
05:01
B2B Tag
Concern in the Cotton Sector over Possible Elimination of Tariff on Imports
[Translated] AcosemillasThe implementation of Decree 1184 on November 8, 2025, which partially modified the Customs Tariff to establish a 0% duty on imports of raw materials and primary products used by the textile and footwear
AgroNegocios
Oct
3rd
2025
09:30
Partnerships and Alliances, CT_Monitor Company
Diagonal Bio initiates collaboration with SVA on evaluation of coronavirus in horses
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company"), with the point-of-care system LAMPlify®, have initiated a collaboration with Swedish Veterinary Agency (SVA) to support the evaluation of testing for equine coronavirus in nasal swabs. The project will be conducted during October and carried out by a Master student from the Swedish University of Agricultural Sciences (SLU) under the supervision of Johanna Lindahl, State veterinarian and Professor in global infection biology.
MFN
Sep
29th
2025
10:35
Events, CT_Monitor Company
Diagonal Therapeutics to Present Preclinical Data on PAH Antibody DIAG723 at 2025 ERS Congress
Diagonal Therapeutics to Present Preclinical Data on PAH Antibody DIAG723 at 2025 ERS Congress by Mark Chiang Share To Diagonal Therapeutics has released preclinical data indicating that its lead clustering antibody, DIAG723, may have disease-modifying potential in treating pulmonary arterial hypertension (PAH).
GeneOnline
Sep
29th
2025
05:06
Events, CT_Monitor Company
Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of DIAG723 in Pulmonary Arterial Hypertension at 2025 ERS Congress
Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of DIAG723 in Pulmonary Arterial Hypertension at 2025 ERS Congress
Le Lézard
Sep
29th
2025
05:00
Events
Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of DIAG723 in Pulmonary Arterial Hypertension at 2025 ERS Congress PR Newswire
Results demonstrate that DIAG723, the Company's lead clustering antibody, can prevent PAH, offering the potential as a first-in-class PAH treatment WATERTOWN, Mass., Sept.
The Greenville Advocate
Sep
23rd
2025
09:15
New Offerings, CT_Monitor Company
Diagonal Bio expands horse testing panel to detect Equine Herpesvirus type 2
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company"), with the point-of-care system LAMPlify®, announces the expansion of its equine testing panel to include the detection of Equine Herpesvirus type 2 (EHV-2). This enhancement broadens the Company’s product portfolio and addresses an unmet need in equine health.
MFN
Sep
7th
2025
18:30
CT_Monitor Company
Grafana & Friends 🤝 Kyndryl
Details Ya estamos de vuelta tras el verano 🚀, y visitaremos las oficinas de Kyndryl en l'Illa Diagonal de Barcelona 💥 📍 Ubicación: c/ Numancia 164, Barcelona | https://maps.app.goo.gl/NiFWVTa7URkSAgey9 📅 Agenda: 18:00: Bienvenida 👋 18:30:
Meetup
Aug
27th
2025
11:00
Funding Activities, CT_Monitor Company
American Rebel Holdings secures $152,950 loan from 1800 Diagonal Lending
American Rebel Holdings, Inc. (NASDAQ:AREB), a small-cap company with a market value of $8.64 million, announced it has entered into a Securities Purchase Agreement with 1800 Diagonal Lending, LLC, according to a statement in a recent SEC filing.
Investing India
Aug
26th
2025
18:30
CT_Monitor Company
Diagonal Investment Office Adds Eduardo Rehder as Wealth Management Senior VP
In order to read this article you will need to subscribe, please click here If you already have an account, Click here to login. ---
Managers of Wealth
Aug
20th
2025
12:08
Events
Tocar una sonata al metro: l’estació de Diagonal tindrà un piano de forma permanent
A preview of this article is not available. Please click on the headline to read the complete article
betevé
Aug
20th
2025
06:00
Regulatory and Legal, CT_Monitor Company
Diagonal Bio AB receives patent approval in Japan
Diagonal Bio AB ("Diagonal Bio" or "the Company"), with its point-of-care analysis system LAMPlify®, has received a confirmation from the Japanese Patent Office that the Company’s patent application regarding “A method of measuring the ph of a sample” (no.: JP7655939) has been granted in Japan.
MFN
Load More…
Analyst insight reports
Protect or plunder Surgical strikes to disrupt industrial-scale piracy
Doing more with less: using technology to drive efficiency in sports production
The rise of super-apps
IBC 2024 | Tech wars noise vs. substance
Subscribe
to access all analyst insight reports
Subscribe for full access to diagonalfilm's products in full detail Subscribe for full access to diagonalfilm's revenue in full detail 
